Kolon TissueGene, Inc. (KOSDAQ:950160)

Kolon TissueGene Revenue

Kolon TissueGene had revenue of 1.41B KRW in the quarter ending March 31, 2026, with 9.49% growth. This brings the company's revenue in the last twelve months to 5.28B, up 2.95% year-over-year. In the year 2025, Kolon TissueGene had annual revenue of 5.16B with 1.68% growth.

• Revenue (ttm): 5.28B
• Revenue Growth: +2.95%
• P/S Ratio: 1,646.28
• Revenue / Employee: 182.10M
• Employees: 29
• Market Cap: 8.69T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.16B	85.27M	1.68%
Dec 31, 2024	5.07B	1.37B	36.90%
Dec 31, 2023	3.71B	-5.75B	-60.81%
Dec 31, 2022	9.46B	5.45B	136.22%
Dec 31, 2021	4.00B	447.31M	12.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error